Further Deregulation in Japan: Devices, Pharmaceuticals Benefit
Despite U.S. companies’ relative success in the Japanese medical device and pharmaceuticals markets, over-regulation has continued to hamper U.S. cutting edge products’ access to Japan’s market. This hurts both U.S. manufacturers and Japanese citizens, who are denied access to innovative, cost-effective, life-saving... Read More